510(k) Report

FDA applicant

R-Biopharm AG

Darmstadt, DE1 decision2017–20170 recalls

FDA records 1 decision for R-Biopharm AG (Darmstadt, DE) in 2017: 1 510(k) clearance. All are in product code PIQ (Reagents For Detection Of Norovirus Nucleic Acid). Its devices cite 1 predicate, 0 of them its own earlier devices. No recall is linked to its devices.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, microbiology panel, where it files most

How often FDA has decided R-Biopharm AG’s devices, and how often a recall has named them.

FDA decisions per year

1in 2017

2017: 1
2017high 1 (2017) · low 0 (2018)2026

2026 so far, outlined.

Recalls per year

No recall linked to its devices since 2017.

FIG. 1 — R-Biopharm AG by year, 2017–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like R-Biopharm AG’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report

Which product codes does it file in?

  • PIQReagents For Detection Of Norovirus Nucleic Acid1decision

Whose devices does it build on?

Its devices cite 1 predicate; 0 are its own earlier devices. The firms it cites most:

What has FDA decided for it lately?

  • K171511RIDA GENE Norovirus GI/GIIR-Biopharm AG · 2017

The one decision as R-Biopharm AG →